Familial hypercholesterolaemia trials in Finland

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  A Study of Enlicitide Decanoate (MK-0616, an Oral PCSK9 Inhibitor) in Children and Adolescents With Heterozygous Familial Hypercholesterolemia (MK-0616-029)

  Where

  Helsinki

  Age

  6 years to 17 years

  People

  153 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07058077 · EU 2024-519068-42-00